This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In “IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease,” Morales-Briceño et al. described a case of anti-IgLON5 disease presenting as cold intolerance, myorhythmia, myoclonus, dysarthria, hypersalivation, dysphagia, sleep apnea, and mildly impaired cognition mimicking CNS Whipple disease. Drs. Bally and Lang report that the presentation in this case was similar to cases of Whipple disease in the literature; however, palatal involvement of the myorhythmia—which was present in the case reported by Morales-Briceño et al.—is rare in Whipple disease, and the cranial myorhythmia in Whipple disease is associated with a vertical supranuclear gaze palsy, which was not present in the case reported by Morales-Briceño et al. Morales-Briceño et al. respond that while the absence of vertical gaze palsy made Whipple disease less likely, such gaze palsies can occur in a certain percentage of patients with IgLON5-mediated neurodegeneration. Both Morales-Briceño et al. and Drs. Bally and Lang agree that the distinction between IgLON5-mediated neurodegeneration and Whipple disease can be challenging.
In “IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease,” Morales-Briceño et al. described a case of anti-IgLON5 disease presenting as cold intolerance, myorhythmia, myoclonus, dysarthria, hypersalivation, dysphagia, sleep apnea, and mildly impaired cognition mimicking CNS Whipple disease. Drs. Bally and Lang report that the presentation in this case was similar to cases of Whipple disease in the literature; however, palatal involvement of the myorhythmia—which was present in the case reported by Morales-Briceño et al.—is rare in Whipple disease, and the cranial myorhythmia in Whipple disease is associated with a vertical supranuclear gaze palsy, which was not present in the case reported by Morales-Briceño et al. Morales-Briceño et al. respond that while the absence of vertical gaze palsy made Whipple disease less likely, such gaze palsies can occur in a certain percentage of patients with IgLON5-mediated neurodegeneration. Both Morales-Briceño et al. and Drs. Bally and Lang agree that the distinction between IgLON5-mediated neurodegeneration and Whipple disease can be challenging.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.